Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Cell Physiol Biochem 13, 257262
( Jiang TA
Groop PH, Cooper ME, Perkovic V, et al
Ispaghula can be a valuable adjunct to a high-fibre diet and healthy lifestyle, but it is not a substitute for evidence-based medical treatment of metabolic or gastrointestinal disorders
)
Tirzepatide, a dual GLP-1/GIP receptor agonist has been approved for glycaemic control in type 2 diabetes as well as for obesity management leading in up to 22.5% WL in phase 3 obesity trials
US$ 26.65
US$ 25.51
US$ 24.89
US$ 25.16
